BPC-157 5MG FOR SALE
Use Coupon Code labz10 to save 10% today!
Data on our BPC-157 for sale
CAS Number: 137525-51-0
Molar Mass: 1,419.5 g/mol
Half life: 4 hours
Experimental Application: Joint and muscle pain, accelerated wound repair.
Storage: Keep refrigerated upon reconstitution.
- Lyophilized sample in sterile glass vial.
- Minimum 98% pure.
- 5mg BPC-157 per vial.
- Diluent and laboratory supplies not included.
What is Body Protection Compound-157 (BPC-157)?
Body Protection Compound-157 (BPC-157) is a derivative peptide composed of 15 amino acids, derived from a much larger molecule found in the human digestive tract called Body Protection Compound (BPC). BPC 157 has been determined to possess many of the same biological properties as its parent source, including wound healing, promotion of healing for damaged blood vessels, and generation of nitric oxide. Studies have further demonstrated that BPC 157 has the ability to modulate immune system function, gene expression, hormone regulation within the Gastrointestinal central nervous system (GINC), as well as promoting normal functioning of the coagulation cascade.
What is BPC 157 and How Does it Provide Cellular Protection?
BPC 157 is a peptide that helps regenerate damage through stimulating fibroblast cells to multiply and migrate more quickly, as well as increasing the synthesis of proteins like collagen, fibrin, and elastin. It also has beneficial effects on endothelial cells that are responsible for lining blood vessels [1-3]. Studies done on rats and chicken embryos showed that BPC 157 promoting collateral vessel growth, opening up potential therapeutic avenues for heart attack and stroke patients [4-8].
Aside from this, BPC 157 is renowned for its ability to naturally fortify the mucosal barrier of the gastrointestinal tract. This occurs without any negative side effects or harm to other areas due to inability to metabolize in healthy tissues. As such, BPC 157 provides an effective way of providing cellular protection without complications.
What are the Benefits of BPC-157 for Peripheral Tissue Healing?
BPC-157 studies have demonstrated promising results in animal models when applied to treating injuries related to connective tissue, such as tendons, ligaments and bones. When these tissues suffer trauma, inadequate blood flow prevents healing cells like fibroblasts from reaching the injury site which reduces recovery time. Research conducted on rats has revealed that BPC-157 can enhance growth factors and increase fibroblast densities around affected tissues after trauma. Ultimately, this improves the speed of tendon healing.
Apart from increasing the rate of healing for tendon injuries, BPC-157 may also be beneficial in increasing the strength of repaired collagen fibers regularly found in connective tissue repair following trauma. When administered directly to an injury site prior to suturing or stapling together a collagen substrate will form a stronger matrix than regular collagen architecture due to increased agglomeration. This indicates that BPC-157 not only increases the amount of fibroblasts at a wound site but also stimulates more robust pathways allowing these cells to link up with neighbouring cells more effectively.
In addition to its effects on connective tissue, BPC-157 is being studied in fields ranging from organ transplants and inflammatory bowel disease allayment through to anti-cancer treatments and type 2 diabetes management due its ability ot modulate different physiological mechanisms that occur during tissue damage. With further research likely to better explore just how effective this peptide can be it appears likely that its scope of applications could expand significantly in forthcoming years.
What is BPC 157 and What are its Antioxidant Functions?
BPC 157, which stands for “Body Protective Compound”, is a peptide agent with antioxidative properties. It has been shown to reduce nitric oxide and malondialdehyde (MDA) levels in animal studies, indicating that it can protect against oxidative stress. The effects of this therapy however have yet to be verified on humans and require clinical trials. Further research has revealed that BPC 157 may decrease the production of reactive oxygen species (ROS) within the gastrointestinal tract in order to provide relief from oxidative damage. Notably, a modified form of lactococcus lactis bacteria was noted to increase cell culture levels of BPC 157 when applied. Thus, it is clear that BPC 157 has antioxidative functions which can help to guard against tissue degradation due to free radicals .
Why Choose Sarm Labz For Your BPC-157 Purchase?
BPC 157 is one of the best peptides for healing and is highly sought after, which can make it difficult to find a reliable supplier. Many companies selling peptides have not properly tested their products and are less than transparent about the certificates from their third-party labs and contact information. That should be a warning sign!
At Sarm Labz, you can confidently purchase BPC 157 with peace of mind knowing that we provide the highest quality peptides available on the internet. All compounds are testified by accredited American third party laboratories and they accept phone calls to validate their certificates. Our shipping process ensures that these sensitive compounds are kept in refrigeration so as to maintain their effectiveness throughout delivery. We offer discreet payment methods for added comfort and transparency, backed up by our 60-day money-back guarantee so that you can always shop with confidence.
In conclusion, Sarm Labz offers premium grade BPC 157 at unbeatable value and reliability. Not only do we take immense pride in providing you with high quality products but our team of customer service representatives are here to answer any queries or questions you have should there be any additional concerns. Buy from us today knowing that you’re getting top notch support as well as unmatched value for your purchase!
1. Drmic D, Samara M, Vidovic T, Malekinusic D, Antunovic M, Vrdoljak B, Ruzman J, Milkovic Perisa M, Horvat Pavlov K, Jeyakumar J, Seiwerth S, Sikiric P. Counteraction of perforated cecum lesions in rats: Effects of pentadecapeptide BPC 157, L-NAME and L-arginine. World J Gastroenterol. 2018 Dec 28;24(48):5462-5476. doi: 10.3748/wjg.v24.i48.5462. PMID: 30622376; PMCID: PMC6319139.
2. Huang T, Zhang K, Sun L, Xue X, Zhang C, Shu Z, Mu N, Gu J, Zhang W, Wang Y, Zhang Y, Zhang W. Body protective compound-157 enhances alkali-burn wound healing in vivo and promotes proliferation, migration, and angiogenesis in vitro. Drug Des Devel Ther. 2015 Apr 30;9:2485-99. doi: 10.2147/DDDT.S82030. PMID: 25995620; PMCID: PMC4425239.
3. Amic F, Drmic D, Bilic Z, Krezic I, Zizek H, Peklic M, Klicek R, Pajtak A, Amic E, Vidovic T, Rakic M, Milkovic Perisa M, Horvat Pavlov K, Kokot A, Tvrdeic A, Boban Blagaic A, Zovak M, Seiwerth S, Sikiric P. Bypassing major venous occlusion and duodenal lesions in rats, and therapy with the stable gastric pentadecapeptide BPC 157, L-NAME and L-arginine. World J Gastroenterol. 2018 Dec 21;24(47):5366-5378. doi: 10.3748/wjg.v24.i47.5366. PMID: 30598581; PMCID: PMC6305534.
4. Duzel A, Vlainic J, Antunovic M, Malekinusic D, Vrdoljak B, Samara M, Gojkovic S, Krezic I, Vidovic T, Bilic Z, Knezevic M, Sever M, Lojo N, Kokot A, Kolovrat M, Drmic D, Vukojevic J, Kralj T, Kasnik K, Siroglavic M, Seiwerth S, Sikiric P. Stable gastric pentadecapeptide BPC 157 in the treatment of colitis and ischemia and reperfusion in rats: New insights. World J Gastroenterol. 2017 Dec 28;23(48):8465-8488. doi: 10.3748/wjg.v23.i48.8465. PMID: 29358856; PMCID: PMC5752708.
5. Vukojević J, Siroglavić M, Kašnik K, Kralj T, Stanćić D, Kokot A, Kolarić D, Drmić D, Sever AZ, Barišić I, Šuran J, Bojić D, Patrlj MH, Sjekavica I, Pavlov KH, Vidović T, Vlainić J, Stupnišek M, Seiwerth S, Sikirić P. Rat inferior caval vein (ICV) ligature and particular new insights with the stable gastric pentadecapeptide BPC 157. Vascul Pharmacol. 2018 Jul;106:54-66. doi: 10.1016/j.vph.2018.02.010. Epub 2018 Mar 3. PMID: 29510201.
6. Drmic D, Kolenc D, Ilic S, Bauk L, Sever M, Zenko Sever A, Luetic K, Suran J, Seiwerth S, Sikiric P. Celecoxib-induced gastrointestinal, liver and brain lesions in rats, counteraction by BPC 157 or L-arginine, aggravation by L-NAME. World J Gastroenterol. 2017 Aug 7;23(29):5304-5312. doi: 10.3748/wjg.v23.i29.5304. PMID: 28839430; PMCID: PMC5550779.
7. Hsieh MJ, Liu HT, Wang CN, Huang HY, Lin Y, Ko YS, Wang JS, Chang VH, Pang JS. Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation. J Mol Med (Berl). 2017 Mar;95(3):323-333. doi: 10.1007/s00109-016-1488-y. Epub 2016 Nov 15. PMID: 27847966.
8. Grabarevic Z, Tisljar M, Artukovic B, Bratulic M, Dzaja P, Seiwerth S, Sikiric P, Peric J, Geres D, Kos J. The influence of BPC 157 on nitric oxide agonist and antagonist induced lesions in broiler chicks. J Physiol Paris. 1997 May-Oct;91(3-5):139-49. doi: 10.1016/s0928-4257(97)89478-8. PMID: 9403788.
9. Škrlec K, Ručman R, Jarc E, Sikirić P, Švajger U, Petan T, Perišić Nanut M, Štrukelj B, Berlec A. Engineering recombinant Lactococcus lactis as a delivery vehicle for BPC-157 peptide with antioxidant activities. Appl Microbiol Biotechnol. 2018 Dec;102(23):10103-10117. doi: 10.1007/s00253-018-9333-6. Epub 2018 Sep 6. PMID: 30191288.